Sino Biopharmaceutical Limited (SBMFF)
OTCMKTS
· Delayed Price · Currency is USD
0.4935
+0.0257 (5.49%)
At close: Apr 22, 2025
Sino Biopharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 8,995 | 7,500 | 8,173 | 10,832 | 13,133 | 18,176 | Upgrade
|
| Market Cap Growth | -6.32% | -8.23% | -24.55% | -17.52% | -27.74% | 3.57% | Upgrade
|
| Enterprise Value | 9,776 | 8,299 | 8,498 | 11,564 | 14,636 | 18,844 | Upgrade
|
| Last Close Price | 0.49 | 0.41 | 0.41 | 0.57 | 0.65 | 0.96 | Upgrade
|
| PE Ratio | 18.76 | 15.64 | 24.85 | 29.37 | 5.71 | 42.82 | Upgrade
|
| PS Ratio | 2.27 | 1.90 | 2.21 | 2.87 | 3.11 | 5.02 | Upgrade
|
| PB Ratio | 1.53 | 1.28 | 1.52 | 1.97 | 2.21 | 5.29 | Upgrade
|
| P/TBV Ratio | 2.13 | 1.78 | 1.96 | 2.59 | 2.84 | 7.22 | Upgrade
|
| P/FCF Ratio | 11.61 | 9.68 | 11.60 | 14.88 | 22.84 | 30.42 | Upgrade
|
| P/OCF Ratio | 9.93 | 8.28 | 9.55 | 11.93 | 15.55 | 22.28 | Upgrade
|
| EV/Sales Ratio | 2.48 | 2.10 | 2.30 | 3.07 | 3.46 | 5.20 | Upgrade
|
| EV/EBITDA Ratio | 10.42 | 8.79 | 9.45 | 12.75 | 17.05 | 21.73 | Upgrade
|
| EV/EBIT Ratio | 12.57 | 10.44 | 11.08 | 14.81 | 20.07 | 30.02 | Upgrade
|
| EV/FCF Ratio | 12.62 | 10.71 | 12.06 | 15.88 | 25.46 | 31.54 | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.23 | 0.33 | 0.37 | 0.33 | 0.63 | Upgrade
|
| Debt / EBITDA Ratio | 1.39 | 1.39 | 1.97 | 2.22 | 2.21 | 2.48 | Upgrade
|
| Debt / FCF Ratio | 1.72 | 1.72 | 2.54 | 2.81 | 3.36 | 3.64 | Upgrade
|
| Asset Turnover | 0.45 | 0.45 | 0.41 | 0.42 | 0.50 | 0.56 | Upgrade
|
| Inventory Turnover | 2.44 | 2.44 | 2.31 | 2.10 | 2.79 | 2.93 | Upgrade
|
| Quick Ratio | 1.11 | 1.11 | 0.90 | 1.15 | 1.38 | 1.87 | Upgrade
|
| Current Ratio | 1.26 | 1.26 | 1.05 | 1.29 | 1.53 | 2.08 | Upgrade
|
| Return on Equity (ROE) | 11.82% | 11.82% | 12.12% | 11.94% | 55.25% | 20.20% | Upgrade
|
| Return on Assets (ROA) | 5.62% | 5.62% | 5.33% | 5.40% | 5.37% | 6.05% | Upgrade
|
| Return on Capital (ROIC) | 7.02% | 7.02% | 6.60% | 6.60% | 6.69% | 7.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.70% | 12.70% | 13.30% | 12.30% | 10.30% | 11.30% | Upgrade
|
| Earnings Yield | 5.33% | 6.39% | 4.02% | 3.40% | 17.51% | 2.33% | Upgrade
|
| FCF Yield | 8.61% | 10.33% | 8.62% | 6.72% | 4.38% | 3.29% | Upgrade
|
| Dividend Yield | 1.56% | 2.17% | 1.54% | 2.69% | 1.58% | 0.98% | Upgrade
|
| Payout Ratio | 52.76% | 52.76% | 27.13% | 49.84% | 6.42% | 42.84% | Upgrade
|
| Buyback Yield / Dilution | 2.36% | 1.26% | 2.57% | 1.38% | -2.57% | 0.06% | Upgrade
|
| Total Shareholder Return | 3.92% | 3.44% | 4.11% | 4.06% | -0.99% | 1.04% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.